GUGGENHEIM CAPITAL LLC - REGULUS THERAPEUTICS INC ownership

REGULUS THERAPEUTICS INC's ticker is RGLSXXXX and the CUSIP is 75915K101. A total of 51 filers reported holding REGULUS THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
GUGGENHEIM CAPITAL LLC ownership history of REGULUS THERAPEUTICS INC
ValueSharesWeighting
Q1 2018$19,000
-29.6%
26,025
+0.6%
0.00%
Q4 2017$27,000
-25.0%
25,867
-11.1%
0.00%
Q3 2017$36,000
-99.0%
29,097
-86.7%
0.00%
-100.0%
Q1 2015$3,720,000
+23.7%
219,573
+17.1%
0.01%
+12.5%
Q4 2014$3,008,000187,5550.01%
Other shareholders
REGULUS THERAPEUTICS INC shareholders Q3 2017
NameSharesValueWeighting ↓
Abingworth LLP 327,350$943,0000.99%
DAFNA Capital Management LLC 421,500$1,218,0000.96%
Rhenman & Partners Asset Management AB 350,000$1,012,0000.18%
BOURGEON CAPITAL MANAGEMENT LLC 70,704$204,0000.13%
Piermont Capital Management Inc. 151,924$439,0000.11%
Virtus ETF Advisers LLC 46,269$134,0000.10%
COLUMBIA PARTNERS L.L.C. INVESTMENT MANAGEMENT 389,144$1,124,0000.08%
GLOBEFLEX CAPITAL L P 80,637$233,0000.06%
South Dakota Investment Council 900,000$2,601,0000.06%
FOX RUN MANAGEMENT, L.L.C. 33,100$96,0000.05%
View complete list of REGULUS THERAPEUTICS INC shareholders